Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_assertion description "[Encouraging preclinical results with ado-trastuzumab emtansine (T-DM1) exemplifies a new potential treatment for HER2-positive BCa along with innovative bispecific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_assertion evidence source_evidence_literature NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_assertion SIO_000772 25498841 NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_assertion wasDerivedFrom befree-2016 NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_assertion wasGeneratedBy ECO_0000203 NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.